{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:27:50Z","timestamp":1730870870244,"version":"3.28.0"},"reference-count":36,"publisher":"Georg Thieme Verlag KG","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1055\/a-2252-7665","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T23:05:51Z","timestamp":1727132751000},"page":"1191-1199","source":"Crossref","is-referenced-by-count":0,"title":["Lungenembolie: ambulante Therapie und Nachsorge"],"prefix":"10.1055","volume":"149","author":[{"given":"Lukas","family":"Hobohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/ATVBAHA.114.304488","article-title":"Thrombosis: a major contributor to global disease burden","volume":"34","author":"GE Raskob","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"09","key":"ref2","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global Burden of Thrombosis: Epidemiologic Aspects","volume":"118","author":"AM Wendelboe","year":"2016","journal-title":"Circ Res"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S2213-2600(19)30354-6","article-title":"Trends in mortality related to pulmonary embolism in the European Region, 2000\u201315: analysis of vital registration data from the WHO Mortality Database","volume":"8","author":"S Barco","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"04","key":"ref4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/eurheartj\/ehz236","article-title":"Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany","volume":"41","author":"K Keller","year":"2020","journal-title":"Eur Heart J"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"SV Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"15","key":"ref6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism","volume":"370","author":"G Meyer","year":"2014","journal-title":"N Engl J Med"},{"issue":"14","key":"ref7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jcin.2018.04.008","article-title":"A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial","volume":"11","author":"VF Tapson","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"04","key":"ref8","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.113.005544","article-title":"Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism","volume":"129","author":"N Kucher","year":"2014","journal-title":"Circulation"},{"issue":"08","key":"ref9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1164\/rccm.201512-2494OC","article-title":"Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule With or Without NT-proBNP Testing in Patients With Acute Pulmonary Embolism: A Randomized Clinical Trial","volume":"194","author":"PL den Exter","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"08","key":"ref10","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1538-7836.2011.04388.x","article-title":"Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study","volume":"9","author":"W Zondag","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/eurheartj\/ehy873","article-title":"Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis","volume":"40","author":"S Barco","year":"2019","journal-title":"Eur Heart J"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/eurheartj\/ehz367","article-title":"Early Discharge and Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. An International Multicentre Single-arm Clinical Trial","volume":"41","author":"S Barco","year":"2020","journal-title":"Eur Heart J"},{"issue":"09","key":"ref13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"G Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"14","key":"ref14","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"HR Buller","year":"2012","journal-title":"N Engl J Med"},{"issue":"13","key":"ref15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome","volume":"132","author":"V Pengo","year":"2018","journal-title":"Blood"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1024\/0301-1526\/a000815","article-title":"Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies","volume":"48","author":"R Bauersachs","year":"2019","journal-title":"Vasa"},{"issue":"02","key":"ref17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report","volume":"149","author":"C Kearon","year":"2016","journal-title":"Chest"},{"issue":"01","key":"ref18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7326\/0003-4819-139-1-200307010-00008","article-title":"Extended oral anticoagulant therapy after a first episode of pulmonary embolism","volume":"139","author":"G Agnelli","year":"2003","journal-title":"Ann Intern Med"},{"issue":"19","key":"ref19","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1001\/archinternmed.2010.367","article-title":"Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review","volume":"170","author":"A Iorio","year":"2010","journal-title":"Arch Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"T Baglin","year":"2003","journal-title":"Lancet"},{"issue":"06","key":"ref21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199702063360601","article-title":"The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group","volume":"336","author":"S Schulman","year":"1997","journal-title":"N Engl J Med"},{"issue":"13","key":"ref22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism","volume":"376","author":"JI Weitz","year":"2017","journal-title":"N Engl J Med"},{"issue":"08","key":"ref23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"G Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"09","key":"ref24","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/jth.14219","article-title":"Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH","volume":"16","author":"AA Khorana","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"20","key":"ref25","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)","volume":"36","author":"AM Young","year":"2018","journal-title":"J Clin Oncol"},{"issue":"07","key":"ref26","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism","volume":"378","author":"GE Raskob","year":"2018","journal-title":"N Engl J Med"},{"issue":"09","key":"ref27","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/s-0038-1668523","article-title":"Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study","volume":"118","author":"G Agnelli","year":"2018","journal-title":"Thromb Haemost"},{"issue":"36","key":"ref29","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1093\/eurheartj\/ehac206","article-title":"Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study","volume":"43","author":"L Valerio","year":"2022","journal-title":"Eur Heart J"},{"issue":"38","key":"ref30","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"M Humbert","year":"2022","journal-title":"Eur Heart J"},{"issue":"20","key":"ref31","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/eurheartj\/ehm295","article-title":"Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients","volume":"28","author":"BG Stevinson","year":"2007","journal-title":"Eur Heart J"},{"issue":"05","key":"ref32","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.chest.2016.11.030","article-title":"Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE Prospective Cohort Study","volume":"151","author":"SR Kahn","year":"2017","journal-title":"Chest"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.thromres.2019.12.008","article-title":"The post-pulmonary syndrome \u2013 results of echocardiographic driven follow up after acute pulmonary embolism","volume":"186","author":"O Dzikowska-Diduch","year":"2020","journal-title":"Thromb Res"},{"issue":"12","key":"ref34","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.jacc.2016.12.039","article-title":"Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism","volume":"69","author":"SV Konstantinides","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref35","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.rmed.2010.06.006","article-title":"Prevalence and potential determinants of exertional dyspnea after acute pulmonary embolism","volume":"104","author":"FA Klok","year":"2010","journal-title":"Respir Med"},{"issue":"11","key":"ref36","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1111\/jth.14589","article-title":"Quality of life and functional limitations after pulmonary embolism and its prognostic relevance","volume":"17","author":"K Keller","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.chest.2021.01.071","article-title":"Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism: Analysis From a Prospective Multicenter Cohort Study","volume":"159","author":"L Valerio","year":"2021","journal-title":"Chest"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2252-7665.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:39:08Z","timestamp":1730817548000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2252-7665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":36,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2024,9,23]]},"published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2252-7665","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"type":"print","value":"0012-0472"},{"type":"electronic","value":"1439-4413"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}